Related Experiment Video
Updated: Jul 17, 2026

14:10
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
16.4K
Targeted Accumulation of Reactive Acrolein via Nanoparticle-embedded Reverse Temperature Hydrogel for Bladder Cancer
Yingying Xu1, Qinglong Du1,2, Zhongwei Zhao1
1Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, China.
Theranostics
|December 8, 2025
Summary
This study introduces a novel nanoparticle hydrogel system for bladder cancer (BC) treatment. It targets tumor metabolism to boost toxic acrolein synthesis, inducing cancer cell death and improving BC therapy.
Area of Science:
- Biochemistry
- Oncology
- Biomaterials
Background:
- Bladder cancer (BC) recurrence after surgery leads to poor outcomes.
- Intravesical drug instillation for BC is limited by poor retention and obstruction.
- Acetylpolyamine oxidase (PAOX) is suppressed in BC, causing polyamine accumulation.
Purpose of the Study:
- To develop a novel intravesical instillation system for bladder cancer treatment.
- To target the metabolic vulnerability of PAOX deficiency in BC.
- To enhance therapeutic efficacy by prolonging drug retention and inducing cancer cell death.
Main Methods:
- Engineered PAOX/targeting peptide-conjugated nanoparticles.
- Developed a reverse temperature hydrogel for in situ gelation and prolonged retention.
- Utilized multi-platform analysis of patient samples and GEO database to confirm PAOX suppression in BC.
Main Results:
- The nanoparticle-hydrogel system synergistically boosted reactive acrolein synthesis, inducing lethal carbonyl stress.
- Treatment disrupted redox homeostasis, causing mitochondrial dysfunction, lipid peroxidation, and DNA damage.
- Acrolein binding to GAPDH promoted P53 upregulation, facilitating apoptosis in BC cells.
Conclusions:
- This strategy targets tumor-specific metabolic vulnerabilities by enhancing acrolein accumulation.
- The system induces multifaceted cell death, offering a promising new approach for BC treatment.
- The combination of nanoparticles and hydrogels enhances drug retention and therapeutic efficacy.

